STUDY QUESTION Is a low (< 1.0 μg/L) or moderately low (1.0–1.9 μg/L) serum anti-
Müllerian hormone (AMH) level a risk factor for early pregnancy loss in IVF/ICSI with a fresh …

STUDY QUESTION Is serum anti-Müllerian hormone (AMH) level predictive of cumulative
live birth (CLB) rate after ART or in women trying to conceive naturally? SUMMARY …

Objective To determine the relation of Anti-Müllerian hormone (AMH) with live birth after in
vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) in women with (extremely) …

Objective To investigate whether serum antimüllerian hormone (AMH) levels are
independently related to miscarriage rates after in vitro fertilization–embryo transfer (IVF-ET) …

The conflicting results from studies on the predictive capabilities of serum anti-Müllerian
hormone (AMH) for IVF pregnancy outcomes may be attributed to small sample sizes and …

Background Anti-Müllerian hormone (AMH) is used as a biomarker to estimate ovarian
reserve. The relationship between AMH and early miscarriage of in vitro fertilization (IVF) is …

This single-centre retrospective observational study was performed at a university IVF
centre. The aim was to examine the predictive power of AMH concentrations for clinical …

Objectives This study aims to examine the capacity of anti-Müllerian hormone (AMH) to
predict cumulative live birth rate (CLBR) following IVF/ICSI within 36 months since start of …

Objectives The aim was to evaluate the association between serum Anti-Müllerian Hormone
(AMH) level and cumulative live birth rates (LBR) in patients undergoing their first in vitro …

Research question Is anti-Müllerian hormone (AMH) serum concentration a useful tool to
predict the outcome of assisted reproductive treatment? Design Retrospective cohort study …